[go: up one dir, main page]

DK1358883T3 - Reepiteliserende farmaceutiske sammensætninger indeholdende xanthangummi - Google Patents

Reepiteliserende farmaceutiske sammensætninger indeholdende xanthangummi

Info

Publication number
DK1358883T3
DK1358883T3 DK02425274T DK02425274T DK1358883T3 DK 1358883 T3 DK1358883 T3 DK 1358883T3 DK 02425274 T DK02425274 T DK 02425274T DK 02425274 T DK02425274 T DK 02425274T DK 1358883 T3 DK1358883 T3 DK 1358883T3
Authority
DK
Denmark
Prior art keywords
xanthan gum
epithelial
pharmaceutical compositions
compositions containing
containing xanthan
Prior art date
Application number
DK02425274T
Other languages
English (en)
Inventor
Maria Grazia Mazzone
Grazia Paladino
Clara Marino
Ornella Peri
Vincenzo Enea
Original Assignee
Sifi Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sifi Spa filed Critical Sifi Spa
Application granted granted Critical
Publication of DK1358883T3 publication Critical patent/DK1358883T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/723—Xanthans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Steroid Compounds (AREA)
DK02425274T 2002-04-30 2002-04-30 Reepiteliserende farmaceutiske sammensætninger indeholdende xanthangummi DK1358883T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02425274A EP1358883B8 (en) 2002-04-30 2002-04-30 Re-epithelializing pharmaceutical compositions containing xanthan gum

Publications (1)

Publication Number Publication Date
DK1358883T3 true DK1358883T3 (da) 2007-11-12

Family

ID=28799773

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02425274T DK1358883T3 (da) 2002-04-30 2002-04-30 Reepiteliserende farmaceutiske sammensætninger indeholdende xanthangummi

Country Status (15)

Country Link
US (5) US8912164B2 (da)
EP (2) EP1913948B1 (da)
JP (2) JP4837912B2 (da)
CN (1) CN100502884C (da)
AT (2) ATE528009T1 (da)
AU (1) AU2003230224B2 (da)
BR (1) BR0304655A (da)
CA (2) CA2484020C (da)
DE (2) DE60221227T2 (da)
DK (1) DK1358883T3 (da)
ES (2) ES2304913T3 (da)
MX (1) MXPA04010668A (da)
PT (1) PT1358883E (da)
RU (1) RU2297230C2 (da)
WO (1) WO2003092706A1 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1913948B1 (en) * 2002-04-30 2011-10-12 Sifi S.p.A. Re-epithelializing pharmaceutical compositions containing xanthan gum
AU2003230321B8 (en) 2002-05-09 2009-07-30 Medigenes A pharmaceutical composition for treatment of wounds containing blood plasma or serum
CN101031310B (zh) * 2004-09-28 2010-10-27 千寿制药株式会社 含有黄原胶和氨基酸的眼科用组合物
ITRM20050443A1 (it) * 2005-08-12 2007-02-13 Opocrin Spa Preparati oftalmici a base di polisaccaridi mucoadesivi con capacita' riepitelizzante della cornea.
US7323184B2 (en) 2005-08-22 2008-01-29 Healagenics, Inc. Compositions and methods for the treatment of wounds and the reduction of scar formation
EP2002841A4 (en) * 2006-03-23 2009-04-15 Senju Pharma Co OPHTHALMIC COMPOSITION WITH XANTHANGUMMI AND GLUCOSE
EP2309980A1 (en) * 2008-07-08 2011-04-20 S.I.F.I. Societa' Industria Farmaceutica Italiana Ophthalmic compositions for treating pathologies of the posterior segment of the eye
JP5620168B2 (ja) * 2010-06-30 2014-11-05 Ｄｓｐ五協フード＆ケミカル株式会社 キシログルカン−カチオン複合体及びそれを含有する安定化組成物
IT1404145B1 (it) * 2010-12-27 2013-11-15 Altergon Sa Composizioni di acido ialuronico stabilizzate verso l'azione di degradazione del calore o degli enzimi
MY172807A (en) * 2011-11-24 2019-12-12 Toyo Sugar Refining Co Ltd Protective agent for keratoconjunctiva or suppressive agent for keratoconjunctival disorder
CN107529760B (zh) * 2015-05-18 2021-05-07 柿原秀己 抗菌物质、液状抗菌剂以及液状抗菌剂的制造方法
RU2767913C2 (ru) * 2015-12-29 2022-03-22 Интервет Интернэшнл Б.В. Вакцина от кокцидиоза
CN106236704A (zh) * 2016-08-30 2016-12-21 上海昊海生物科技股份有限公司 一种兼具仿生和靶向功能的莫西沙星滴眼液及其制备方法
JP7569336B2 (ja) 2019-06-11 2024-10-17 サイファイ エス．ピー．エー． マイクロエマルション組成物
IT202000002296A1 (it) * 2020-02-06 2021-08-06 Sifi Spa Formulazioni topiche oftalmiche a base di xantano con ridotta posologia
IT202000015457A1 (it) * 2020-06-26 2021-12-26 Sifi Spa Composizione oftalmica e suo uso nel trattamento di patologie dell’occhio
MX2021003369A (es) * 2021-03-22 2022-09-23 Laboratorios Grin S A De C V Lágrima ocular triple.
IT202200000821A1 (it) * 2022-01-19 2023-07-19 Sifi Spa Formulazioni topiche oftalmiche a base di xantano con ridotta posologia

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136177A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Xanthan gum therapeutic compositions
US4370324A (en) 1980-09-17 1983-01-25 Bernstein Joel E Method and composition for treating and preventing irritation of the eyes
US4525346A (en) 1981-09-28 1985-06-25 Alcon Laboratories, Inc. Aqueous antimicrobial ophthalmic solutions
US4711780A (en) * 1984-06-11 1987-12-08 Fahim Mostafa S Composition and process for promoting epithelial regeneration
US4826872A (en) 1986-12-03 1989-05-02 Takeda Chemical Industries, Ltd. Pharmaceutical composition for treatment of cataract
JPH0723317B2 (ja) * 1988-03-17 1995-03-15 生化学工業株式会社 角膜上皮層障害症治療剤
JPH0651638B2 (ja) * 1989-02-13 1994-07-06 新技術事業団 角膜上皮創傷治療用点眼剤
US5271943A (en) * 1989-10-27 1993-12-21 Scott Health Care Wound gel compositions containing sodium chloride and method of using them
IT1243435B (it) * 1990-10-05 1994-06-10 Altergon Sa Composizioni farmaceutiche per uso topico comprendenti acido ialuronico sale sodico e sostanze disinfettanti
US5804213A (en) * 1991-10-09 1998-09-08 Lectec Corporation Biologically active aqueous gel wound dressing
US6277365B1 (en) * 1997-09-18 2001-08-21 Bausch & Lomb Incorporated Ophthalmic composition including a cationic glycoside and an anionic therapeutic agent
JP4545927B2 (ja) * 1998-04-07 2010-09-15 アルコン ラボラトリーズ， インコーポレイテッド キサンタンガムを含有するゲル化眼科用組成物
DE20022450U1 (de) * 1999-01-19 2002-01-17 Dr. Gerhard Mann Chem.-pharm. Fabrik GmbH, 13581 Berlin Künstliche Tränenflüssigkeit in Gelform
AU2000269264A1 (en) * 2000-08-23 2002-03-04 Eidgenossische Technische Hochschule Zurich (Eth) Treatment of trauma, and other indications
AU2002232437A1 (en) * 2000-12-20 2002-07-01 Alcon Universal Ltd. Ophthalmic lubricating solution adapted for use in lasik surgery
RU2190388C1 (ru) * 2001-06-09 2002-10-10 Высоков Виктор Игоревич Средство на основе масла чайного дерева (варианты)
EP1913948B1 (en) * 2002-04-30 2011-10-12 Sifi S.p.A. Re-epithelializing pharmaceutical compositions containing xanthan gum

Also Published As

Publication number Publication date
AU2003230224B2 (en) 2008-07-17
EP1913948B1 (en) 2011-10-12
ATE528009T1 (de) 2011-10-15
DE60221227T2 (de) 2008-01-31
JP2005529906A (ja) 2005-10-06
ES2304913T1 (es) 2008-11-01
EP1358883A1 (en) 2003-11-05
EP1913948A1 (en) 2008-04-23
CA2484020C (en) 2011-10-25
ES2304913T3 (es) 2012-03-01
CA2484020A1 (en) 2003-11-13
ES2290264T3 (es) 2008-02-16
US8912164B2 (en) 2014-12-16
CN100502884C (zh) 2009-06-24
US20080146530A1 (en) 2008-06-19
WO2003092706A1 (en) 2003-11-13
DE60221227D1 (de) 2007-08-30
US20080139522A1 (en) 2008-06-12
US20080139502A1 (en) 2008-06-12
EP1358883B8 (en) 2007-10-03
RU2297230C2 (ru) 2007-04-20
AU2003230224A1 (en) 2003-11-17
ATE367165T1 (de) 2007-08-15
US20160166601A1 (en) 2016-06-16
JP2011102315A (ja) 2011-05-26
US20050234011A1 (en) 2005-10-20
PT1358883E (pt) 2007-10-01
BR0304655A (pt) 2004-07-20
JP5203472B2 (ja) 2013-06-05
JP4837912B2 (ja) 2011-12-14
EP1358883B1 (en) 2007-07-18
DE07108593T1 (de) 2008-12-04
CN1649602A (zh) 2005-08-03
CA2749172C (en) 2013-04-09
RU2004131550A (ru) 2005-06-10
MXPA04010668A (es) 2005-06-20
CA2749172A1 (en) 2003-11-13

Similar Documents

Publication Publication Date Title
DK1358883T3 (da) Reepiteliserende farmaceutiske sammensætninger indeholdende xanthangummi
DK1157037T3 (da) GCSF-konjugater
DE60236541D1 (de) Inhibitoren von 11-beta-hydroxysteroiddehydrogenase typ 1
ATE551988T1 (de) Orale zusammensetzungen, ihre herstellung und verwendung
BRPI0415449A (pt) combinações de compostos ativos fungicidas sinergìsticos
IS8487A (is) Nefholssamsetning af rótigótíni
BRPI0508579A (pt) composto, composição farmacêutica, e, uso de um composto
ATE447397T1 (de) Darreichungsform mit erhöhter bioverfügbarkeit
IL208697A0 (en) Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol
ATE486587T1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
ATE419038T1 (de) Formulierungen enthaltend melatonin, ginkgo biloba und biotin
NO20041509L (no) Rengjoringspreparat.
DE602004019083D1 (de) Sauerstoffbarriereformulierungen
MY139522A (en) New alkyl-pyridines as 11-beta inhibitors for diabetes
AR059113A1 (es) Composicion para administracion topica
CA2529441A1 (en) Use of hyaluronic acid for preparing compositions for treating oral cavity aphthas
DE602004003752D1 (de) Zahnweissmittel enthaltend Natriummagnesiumsilikat und Harnstoffperoxid
ATE412404T1 (de) Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon
TW200502235A (en) Novel benzo[1,2,5]thiadiazoles and pharmaceutical use thereof
ATE359350T1 (de) Verdickte wässrige zusammensetzungen
AR057648A1 (es) Composicion de metaflumizona para la administracion topica
ATE526833T1 (de) Teigzusammensetzung enthaltend eingekapselte organische säure und antimikrobiellen wirkstoff
ATE307102T1 (de) 3,3-dimethylcyclohexan-derivate
ATE301469T1 (de) Pharmazeutische diclofenac-verbindung basierend auf vitamin e, papain und hyaluronidase
BR0314874A (pt) Composição de tiofeno anti-helmìntica e inseticidas